Exact Sciences Corporation – NASDAQ:EXAS

Add to watchlist

$46.41

-11.14

-19.36%

Market closed

Open in 2 days

+24.14%

month

+24.14%

quarter

-23.96%

year

Market Cap	10.78B
Enterprise value	14.06B

P/E	-18.35
EV/Sales	6.74
EV/EBITDA	-33.39
Price/Sales	5.68
Price/Book	3.89
PEG ratio	10.64
EPS	-1.31

Revenue	2.53B
EBITDA	-86.90M
Income	-240.22M
Revenue Q/Q	5.82%
Revenue Y/Y	15.21%

Profit margin	-29.91%
Oper. margin	-27.71%
Gross margin	72.44%
EBIT margin	-27.71%
EBITDA margin	-3.43%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Exact Sciences Stock Forecast

M Q Y

Last Year

$78.63

Potential upside: 69.41%

Analysts Price target
Financials & Ratios estimates

Exact Sciences Corporation (NASDAQ:EXAS): Profit margin
Jun 2023	622.09M	-81.02M	-13.02%
Sep 2023	628.33M	794K	0.13%
Dec 2023	646.88M	-49.76M	-7.69%
Mar 2024	637.52M	-110.22M	-17.29%

Exact Sciences Corporation (NASDAQ:EXAS): Debt to assets
Jun 2023	6355563000	3.29B	51.91%
Sep 2023	6420830000	3.29B	51.39%
Dec 2023	6471334000	3.32B	51.4%
Mar 2024	6376321000	3.24B	50.87%

Exact Sciences Corporation (NASDAQ:EXAS): Cash Flow
Jun 2023	100.42M	66.47M	16.04M
Sep 2023	24.36M	-32.96M	92K
Dec 2023	69.54M	-66.76M	10.03M
Mar 2024	-82.31M	-171.43M	-3.00M

Exact Sciences alternative data

Exact Sciences Corporation (NASDAQ:EXAS): Job openings
Sep 2023	176
Oct 2023	158
Nov 2023	165
Dec 2023	122
Jan 2024	130
Feb 2024	181
Apr 2024	324
May 2024	214
Jun 2024	234
Jul 2024	180
Dec 2024	345

Exact Sciences
Employees

Exact Sciences Corporation (NASDAQ:EXAS): Employee count
Sep 2023	6,300
Oct 2023	6,300
Nov 2023	6,300
Dec 2023	6,300
Jan 2024	6,300
Feb 2024	6,300
Mar 2024	6,500
Apr 2024	6,500
May 2024	6,500
Jun 2024	6,500
Jul 2024	6,500

Exact Sciences
Hedge Funds Holdings Q2 2022

92.08% -3.54%

of EXAS is owned by hedge funds

474 -55

hedge funds hold EXAS stock

160.60M -4.29M

shares is hold by hedge funds

EXAS hedge funds holdings changes

Exact Sciences
Insider Trading

Exact Sciences Corporation (NASDAQ:EXAS): Insider trades (number of shares)
Period	Buy	Sel
Dec 2023	0	2000
Jan 2024	0	2879
Feb 2024	0	50579
Mar 2024	0	29158
Apr 2024	0	2924
May 2024	0	1838
Sep 2024	0	929
Oct 2024	0	929
Nov 2024	19500	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	13 Nov 2024	CONROY KEVIN T director, officer: President and CEO director, officer: President an..	Common Stock	19,500	$51.35	$1,001,325
Sale	8 Oct 2024	BARANICK BRIAN officer: EVP, GM, Precision Oncology officer: EVP, GM, Precision Onc..	Common Stock	929	$70	$65,030
Sale	18 Sep 2024	BARANICK BRIAN officer: EVP, GM, Precision Oncology officer: EVP, GM, Precision Onc..	Common Stock	929	$70	$65,030
Option	5 Aug 2024	BARANICK BRIAN officer: EVP, GM, Precision Oncology officer: EVP, GM, Precision Onc..	Common Stock	2,712	N/A	N/A
Option	5 Aug 2024	BARANICK BRIAN officer: EVP, GM, Precision Oncology officer: EVP, GM, Precision Onc..	Restricted Stock Units	2,712	N/A	N/A
Sale	1 May 2024	COWARD D SCOTT director	Common Stock	67	$60.15	$4,030
Sale	1 May 2024	CUNNINGHAM EVERETT officer: Chief Commercial Officer officer: Chief Commercial Officer	Common Stock	136	$60.15	$8,180
Sale	1 May 2024	HERRIOTT JAMES officer: SVP, General Counsel & Sec officer: SVP, General Counsel &..	Common Stock	30	$60.15	$1,805
Sale	1 May 2024	ELLIOTT JEFFREY THOMAS officer: Chief Financial Officer officer: Chief Financial Officer	Common Stock	136	$60.15	$8,180
Sale	1 May 2024	CONDELLA SARAH officer: EVP, Human Resources officer: EVP, Human Resources	Common Stock	102	$60.15	$6,135

EXAS insider trading transactions

Status	Patent	Filling date	Issue date
Application	Application MULTIPLEX AMPLIFICATION DETECTION ASSAY Filling date: 11 Mar 2022 Issue date: 25 Aug 2022	11 Mar 2022	25 Aug 2022
Application	Application DETECTING THE PRESENCE OR ABSENCE OF MULTIPLE TYPES OF CANCER Filling date: 28 Jan 2022 Issue date: 4 Aug 2022	28 Jan 2022	4 Aug 2022
Grant	Grant Utility: Method for stabilizing hemoglobin and reagents for performing the same Filling date: 15 Mar 2019 Issue date: 12 Jul 2022	15 Mar 2019	12 Jul 2022
Grant	Grant Utility: Detecting colorectal neoplasm Filling date: 30 Apr 2019 Issue date: 21 Jun 2022	30 Apr 2019	21 Jun 2022
Grant	Grant Utility: Methylated control DNA Filling date: 19 Jul 2017 Issue date: 31 May 2022	19 Jul 2017	31 May 2022
Application	Application DETECTING PANCREATIC DUCTAL ADENOCARCINOMA IN PLASMA Filling date: 3 Apr 2020 Issue date: 26 May 2022	3 Apr 2020	26 May 2022
Application	Application NUCLEIC ACID CONTROL MOLECULES FROM NON-HUMAN ORGANISMS Filling date: 18 Nov 2021 Issue date: 5 May 2022	18 Nov 2021	5 May 2022
Grant	Grant Utility: Multiplex amplification detection assay Filling date: 29 May 2020 Issue date: 12 Apr 2022	29 May 2020	12 Apr 2022
Application	Application SAMPLE COLLECTION DEVICE Filling date: 28 Apr 2021 Issue date: 12 Aug 2021	28 Apr 2021	12 Aug 2021
Application	Application ERGONOMIC STOOL SPECIMEN CONTAINER AND ENCLOSING HOLDER SYSTEMS, METHODS, AND KITS Filling date: 6 Nov 2020 Issue date: 3 Jun 2021	6 Nov 2020	3 Jun 2021

Exact Sciences
Earnings Call Transcripts

Quarter	Transcript
Q1 2024 8 May 2024	Q1 2024 Earnings Call Transcript
Q4 2023 21 Feb 2024	Q4 2023 Earnings Call Transcript
Q3 2023 1 Nov 2023	Q3 2023 Earnings Call Transcript
Q2 2023 1 Aug 2023	Q2 2023 Earnings Call Transcript

EXAS earnings call transcripts

Exact Sciences
Executives

Insider	Age	Compensation
Mr. Kevin T. Conroy (1966) Chairman, Pres & Chief Executive Officer	59	$1,920,000
Mr. Graham P. Lidgard (1949) Emeritus Chief Science Officer	76	$852,840
Mr. Jeffrey T. Elliott CFA (1978) Executive Vice President, Chief Financial Officer & Chief Operating Officer	47	$847,380
Mr. D. Scott Coward (1965) Chief Admin. Officer, Executive Vice President, Gen. Counsel & Sec.	60	$826,600
Mr. Jake Orville (1974) Gen. Mang. of Pipeline	51	$651,430

Exact Sciences
Latest News

Monday, 9 December 2024
10:01	AAPA Awarded Grant from Exact Sciences to Improve Colorectal Cancer Screening Rates	globenewswire.com
Wednesday, 4 December 2024
11:06	Exact Sciences Corporation (EXAS) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)	seekingalpha.com
Tuesday, 3 December 2024
12:02	Exact Sciences Corporation (EXAS) Citi's 2024 Global Healthcare Conference (Transcript)	seekingalpha.com
Monday, 2 December 2024
09:30	Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening	businesswire.com
Tuesday, 26 November 2024
13:24	Why Is Exact Sciences Stock Trading Higher On Tuesday? (CORRECTED)	benzinga.com
12:21	Why Is Exact Sciences Stock Trading Higher On Monday?	benzinga.com
06:00	Exact Sciences to Participate in December Investor Conferences	businesswire.com
Monday, 25 November 2024
17:35	Exact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024	businesswire.com
Tuesday, 19 November 2024
16:07	Exact Sciences Corporation (EXAS) Jefferies London Healthcare Conference (Transcript)	seekingalpha.com
Monday, 18 November 2024
08:10	EXAS Stock Set to Benefit From Favorable Study Data Backing MCED Test	zacks.com
Wednesday, 13 November 2024
13:00	Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy	businesswire.com
Sunday, 10 November 2024
11:39	Exact Sciences: Cancer Detection Stalwart's Bad Quarter Resets Its Overgrown Market Cap.	seekingalpha.com
Wednesday, 6 November 2024
12:36	Cologuard Maker Exact Sciences Slashes Outlook as Losses Mount	investopedia.com
10:13	Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point	benzinga.com
08:55	Exact Sciences Stock Down on Q3 Earnings & Revenue Miss, '24 View Cut	zacks.com
07:58	Exact Sciences Posts Downbeat Results, Joins Super Micro Computer, Honda Motor And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session	benzinga.com
Tuesday, 5 November 2024
21:06	Exact Sciences Corporation (EXAS) Q3 2024 Earnings Call Transcript	seekingalpha.com
20:42	Exact Sciences Stock Falls 29% On Weak Results, Downbeat Outlook	investors.com
18:30	Exact Sciences (EXAS) Reports Q3 Loss, Lags Revenue Estimates	zacks.com
Monday, 4 November 2024
15:01	3 Large-Cap Stocks to Buy Ahead of Likely Earnings Beat Tuesday	zacks.com
09:56	Why Investors Need to Take Advantage of These 2 Medical Stocks Now	zacks.com
Friday, 1 November 2024
06:00	Exact Sciences to Participate in November Investor Conference	businesswire.com
Tuesday, 29 October 2024
13:01	Exact Sciences (EXAS) Moves to Strong Buy: Rationale Behind the Upgrade	zacks.com
09:56	Why Investors Need to Take Advantage of These 2 Medical Stocks Now	zacks.com
Sunday, 27 October 2024
12:00	Exact Sciences Presents Multiple Studies at ACG 2024 Demonstrating Leadership in Noninvasive Colorectal Cancer Screening and Patient Engagement	businesswire.com
Tuesday, 22 October 2024
13:47	Will Screening Sales Drive Exact Sciences' Q3 Earnings?	zacks.com
Thursday, 17 October 2024
08:00	Can This Beaten-Down Cathie Wood Stock Bounce Back?	fool.com
Thursday, 10 October 2024
10:15	EXAS Gains FDA Nod for Cologuard Plus, Progresses With CRC Screening	zacks.com
Tuesday, 8 October 2024
06:00	Exact Sciences Schedules Third Quarter 2024 Earnings Call	businesswire.com
Monday, 7 October 2024
14:05	FMR LLC Bolsters Stake in Exact Sciences Corp	gurufocus.com

Ideas & Opinions

Seeking Alpha 8 Aug 2025

Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025
Seeking Alpha 14 Jun 2024

Undercovered Dozen June 7-13: TeraWulf, Luckin Coffee, iHeartMedia And More
Seeking Alpha 4 Apr 2024

Bio-Techne: Secular Growth Opportunities Always Exhibit Financial Excellence
Seeking Alpha 25 Jan 2024

Exact Sciences: Growing Revenue With An Innovative Approach To Oncology
Seeking Alpha 16 Aug 2023

Exact Sciences: Adjusting My Strategy After Encouraging Q2 Earnings
Seeking Alpha 19 Jul 2023

Exact Sciences: Revolutionizing Cancer Detection With Innovation
Seeking Alpha 22 Jun 2023

Exact Sciences: The Future Of Colorectal Cancer Screening And The Impact Of BLUE-C Study Results
Seeking Alpha 29 Apr 2023

Exact Sciences: Ready To Benefit From Aging Millennials
Seeking Alpha 20 Apr 2023

Guardant Health: On Hold For Now
Seeking Alpha 6 Apr 2023

Exact Sciences Leads The Way In Low-Cost Cancer Screening

Frequently Asked Questions (FAQ)

What's the price of Exact Sciences stock today?

One share of Exact Sciences stock can currently be purchased for approximately $46.41.
When is Exact Sciences's next earnings date?

Unfortunately, Exact Sciences's (EXAS) next earnings date is currently unknown.
Does Exact Sciences pay dividends?

No, Exact Sciences does not pay dividends.
How much money does Exact Sciences make?

Exact Sciences has a market capitalization of 10.78B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 19.93% to 2.5B US dollars.
What is Exact Sciences's stock symbol?

Exact Sciences Corporation is traded on the NASDAQ under the ticker symbol "EXAS".
What is Exact Sciences's primary industry?

Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
How do i buy shares of Exact Sciences?

Shares of Exact Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Exact Sciences's key executives?
Exact Sciences's management team includes the following people:
- Mr. Kevin T. Conroy Chairman, Pres & Chief Executive Officer(age: 59, pay: $1,920,000)
- Mr. Graham P. Lidgard Emeritus Chief Science Officer(age: 76, pay: $852,840)
- Mr. Jeffrey T. Elliott CFA Executive Vice President, Chief Financial Officer & Chief Operating Officer(age: 47, pay: $847,380)
- Mr. D. Scott Coward Chief Admin. Officer, Executive Vice President, Gen. Counsel & Sec.(age: 60, pay: $826,600)
- Mr. Jake Orville Gen. Mang. of Pipeline(age: 51, pay: $651,430)
How many employees does Exact Sciences have?

As Jul 2024, Exact Sciences employs 6,500 workers.
When Exact Sciences went public?

Exact Sciences Corporation is publicly traded company for more then 24 years since IPO on 1 Feb 2001.
What is Exact Sciences's official website?

The official website for Exact Sciences is exactsciences.com.
Where are Exact Sciences's headquarters?

Exact Sciences is headquartered at 5505 Endeavor Lane, Madison, WI.
How can i contact Exact Sciences?

Exact Sciences's mailing address is 5505 Endeavor Lane, Madison, WI and company can be reached via phone at +60 82 845 700.
What is Exact Sciences stock forecast & price target?

Based on 6 Wall Street analysts` predicted price targets for Exact Sciences in the last 12 months, the avarage price target is $78.63. The average price target represents a 69.41% change from the last price of $46.41.

Exact Sciences Corporation

exactsciences.com

Exchange:

NASDAQ

Full time employees:

6,500

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

+60 82 845 700

5505 Endeavor Lane
Madison, WI 53719

CIK: 0001124140
ISIN: US30063P1057
CUSIP: 30063P105